Why the study?
Recommendations for long-term loop diuretic titration schemes have not been finalized, major prospective randomized trials on morbidity and mortality are lacking, and optimizing therapy in chronic heart failure remains a challenge.
Population
Patients with chronic heart failure
Design
Review
Authors
Loading...
Diuretics should be considered to reduce HF hospitalizations; reinforces loop diuretic use as mainstay in chronic HF management.
This review highlights the pharmacological differences between loop diuretics in heart failure, noting torasemide's potential advantages over furosemide while emphasizing the need for individualized titration strategies.
Gafurova et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: